more generic ARBs in 2012
You'll see more generic ARBs in 2012...irbesartan (Avapro) in March...valsartan (Diovan) in Sept...and candesartan (Atacand) in Dec.
But this DOESN'T mean ARBs should be used first-line instead of ACE inhibitors. ACEIs still have more evidence for improving outcomes.
Continue to suggest saving ARBs for patients who can't take an ACEI.